P-SCN-Bn-DOTA (Standard)
P-SCN-Bn-DOTA (Standard) is the analytical standard of p-SCN-Bn-DOTA. This product is intended for research and analytical applications. p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor[1][2].
Product Specifications
CAS Number
[127985-74-4]
UNSPSC
12352100
Target
Others; Reference Standards
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(O)CN1C(CC2=CC=C(N=C=S)C=C2)CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1
Molecular Formula
C24H33N5O8S
Molecular Weight
551.61
References & Citations
[1]Vera DRB, et, al. Preclinical evaluation of (177) lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm. 2011 Jun;26 (3) :287-97.|[2]Giannini G, et, al. Synthesis and preliminary in vitro evaluation of DOTA-Tenatumomab conjugates for theranostic applications in tenascin expressing tumors. Bioorg Med Chem. 2019 Aug 1;27 (15) :3248-3253.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
V2110-16N 100 µg
VEGFR1 (Vascular Endothelial Growth Factor Receptor 1, VEGFR-1, Fms-like Tyrosine Kinase 1, FLT-1, Tyrosine-protein Kinase FRT, Tyrosine-protein Kinase Receptor FLT, Vascular Permeability Factor Receptor, FLT1, FLT, FRT)
Ask
View Details 